206 related articles for article (PubMed ID: 25649771)
1. ERK5 is a critical mediator of inflammation-driven cancer.
Finegan KG; Perez-Madrigal D; Hitchin JR; Davies CC; Jordan AM; Tournier C
Cancer Res; 2015 Feb; 75(4):742-53. PubMed ID: 25649771
[TBL] [Abstract][Full Text] [Related]
2. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.
Yamamoto H; Ryu J; Min E; Oi N; Bai R; Zykova TA; Yu DH; Moriyama K; Bode AM; Dong Z
J Invest Dermatol; 2017 Jun; 137(6):1322-1332. PubMed ID: 28131816
[TBL] [Abstract][Full Text] [Related]
3. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
[TBL] [Abstract][Full Text] [Related]
4. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.
Wu L; Chen X; Zhao J; Martin B; Zepp JA; Ko JS; Gu C; Cai G; Ouyang W; Sen G; Stark GR; Su B; Vines CM; Tournier C; Hamilton TA; Vidimos A; Gastman B; Liu C; Li X
J Exp Med; 2015 Sep; 212(10):1571-87. PubMed ID: 26347473
[TBL] [Abstract][Full Text] [Related]
5. Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotion.
Maalouf SW; Theivakumar S; Owens DM
J Dermatol Sci; 2012 May; 66(2):108-18. PubMed ID: 22464766
[TBL] [Abstract][Full Text] [Related]
6. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.
Alitalo AK; Proulx ST; Karaman S; Aebischer D; Martino S; Jost M; Schneider N; Bry M; Detmar M
Cancer Res; 2013 Jul; 73(14):4212-21. PubMed ID: 23695550
[TBL] [Abstract][Full Text] [Related]
7. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.
Pearson HB; McGlinn E; Phesse TJ; Schlüter H; Srikumar A; Gödde NJ; Woelwer CB; Ryan A; Phillips WA; Ernst M; Kaur P; Humbert P
Mol Cancer; 2015 Sep; 14():169. PubMed ID: 26376988
[TBL] [Abstract][Full Text] [Related]
8. Epidermal FABP Prevents Chemical-Induced Skin Tumorigenesis by Regulation of TPA-Induced IFN/p53/SOX2 Pathway in Keratinocytes.
Zhang Y; Hao J; Zeng J; Li Q; Rao E; Sun Y; Liu L; Mandal A; Landers VD; Morris RJ; Cleary MP; Suttles J; Li B
J Invest Dermatol; 2018 Sep; 138(9):1925-1934. PubMed ID: 29559340
[TBL] [Abstract][Full Text] [Related]
9. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
11. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
Duperret EK; Oh SJ; McNeal A; Prouty SM; Ridky TW
Cell Cycle; 2014; 13(10):1551-9. PubMed ID: 24626198
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.
Indra AK; Castaneda E; Antal MC; Jiang M; Messaddeq N; Meng X; Loehr CV; Gariglio P; Kato S; Wahli W; Desvergne B; Metzger D; Chambon P
J Invest Dermatol; 2007 May; 127(5):1250-60. PubMed ID: 17301838
[TBL] [Abstract][Full Text] [Related]
13. Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
Sato Y; Fujimura T; Hidaka T; Lyu C; Tanita K; Matsushita S; Yamamoto M; Aiba S
Front Immunol; 2020; 11():534323. PubMed ID: 33178182
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.
Charlson AT; Zeliadt NA; Wattenberg EV
Toxicol Appl Pharmacol; 2009 Dec; 241(2):143-53. PubMed ID: 19716839
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
16. ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway.
Yue B; Ren QX; Su T; Wang LN; Zhang L
Eur Rev Med Pharmacol Sci; 2014; 18(18):2640-7. PubMed ID: 25317798
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis.
Kim DJ; Angel JM; Sano S; DiGiovanni J
Oncogene; 2009 Feb; 28(7):950-60. PubMed ID: 19137019
[TBL] [Abstract][Full Text] [Related]
18. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
19. Smad7 Ameliorates TGF-β-Mediated Skin Inflammation and Associated Wound Healing Defects but Not Susceptibility to Experimental Skin Carcinogenesis.
Li F; Bian L; Iriyama S; Jian Z; Fan B; Luo J; Wang DD; Young CD; Han G; Wang XJ
J Invest Dermatol; 2019 Apr; 139(4):940-950. PubMed ID: 30423327
[TBL] [Abstract][Full Text] [Related]
20. The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
Xu Q; Zhang J; Telfer BA; Zhang H; Ali N; Chen F; Risa B; Pearson AJ; Zhang W; Finegan KG; Ucar A; Giurisato E; Tournier C
Oncogene; 2021 Jun; 40(23):3929-3941. PubMed ID: 33981002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
